MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
ANVS Annovis Bio
- 4.370
- -0.030-0.68%
Close Dec 20 16:00 ET
- 4.370
- 0.0000.00%
Post 20:01 ET
60.29MMarket Cap-1.04P/E (TTM)
4.530High4.300Low330.16KVolume4.460Open4.400Pre Close1.45MTurnover3.01%Turnover RatioLossP/E (Static)13.80MShares22.49052wk High8.54P/B47.99MFloat Cap4.30052wk Low--Dividend TTM10.98MShs Float132.000Historical High--Div YieldTTM5.23%Amplitude2.418Historical Low4.385Avg Price1Lot Size
About Annovis Bio Company
Annovis Bio, Inc. is a clinical stage drug platform company, which engages in the development of drugs which aim to treat neurodegenerative diseases such as Alzheimer's (AD) and Parkinson's (PD). Its lead product candidate, Buntanetap, is designed to address AD, PD, and potentially other chronic neurodegenerative diseases. Its product pipeline also includes ANVS405 and ANVS301, which focus on the treatment of traumatic brain injury, stroke, and advanced AD. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Malvern, PA.
Company Profile
SymbolANVS
Company NameAnnovis Bio
Listing DateJan 29, 2020
Issue Price6.00
Founded2008
CEODr. Maria Maccecchini, PhD
MarketNYSE
Employees6
Fiscal Year Ends12-31
Address101 Lindenwood Drive,Suite 225
CityMalvern
ProvincePennsylvania
CountryUnited States of America
Zip Code19355
Phone1-484-875-3192
Websitehttp://www.annovisbio.com
Company Executives
- Name
- Position
- Salary
- Dr. Maria Maccecchini, PhD
- Director, President and Chief Executive Officer
- 2.15M
- William Fricker
- Interim Chief Financial Officer
- --
- Michael M.B. Hoffman
- Chairman of the Board
- 153.92K
- Reid S. McCarthy
- Independent Director
- 143.92K
- Dr. Claudine E. Bruck, PhD
- Independent Director
- 135.43K
- Mark White
- Independent Director
- 135.43K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.